HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • >CMDh
  • >Procedural Guidance
  • >eSubmissions
  • CMDh
    • About CMDh
    • Statistics
    • Agendas and Minutes
    • Press Releases
    • COVID-19
    • BREXIT
    • Nitrosamine impurities
    • Procedural Guidance
      • General Info
      • Application for MA
      • eSubmissions
      • Generics
      • Applicant´s Responses
      • Renewal
      • Consultation with target patient groups
      • Variation
      • USR
      • Art 61.3 Procedure
      • Post Referral Phase
    • CMDh-Referrals
    • Product Information
    • Advice from CMDh
    • Templates
    • CMD Working Parties / Working Groups
    • Paediatric Regulation
    • Pharmacovigilance
    • Falsified Medicines
    • Questions & Answers
    • Contact Points
    • Recently Published history
  • MRI Product Index
  • Pharmacovigilance
  • Availability of Medicines
  • Publications and reports
  • National Contacts

 

eSubmissions

Further guidance on eSubmissions can be found on the EMA website under eSubmission

 

  • Information on how to submit electronic applications within MRP, DCP and National procedures via the CESP portal is found on the CESP (hma.eu) website.
  • CMDh Best Practice Guide on the use of eCTD in the MRP/DCP (April 2020) [Track version]
  • Requirements on Submissions for New Marketing Authorisation Applications within MRP, DCP and National Procedures (July 2024) [Track version]
  • Requirements on submissions for Variations and Renewals within MRP and National Procedures (July 2024) [Track version]

Questions & Answers on eSubmissions

  • Questions and answers
  • Question and answer document covering practical issues for variations in eCTD format
  • Q&A on how to handle ongoing procedures in relation to mandatory eCTD format
  • Q&A on mandatory eCTD in National Procedures (NP)

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/human-medicines/cmdh/procedural-guidance/esubmissions.html
OSZAR »